Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
PMV Pharmaceuticals, Inc. (PMVP) had Stock-Based Compensation of $5.92M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-18.04M |
|
-- |
|
-- |
|
$19.24M |
|
$-19.24M |
|
$1.23M |
|
$-18.01M |
|
$-18.01M |
|
$-18.04M |
|
$-18.04M |
|
$-18.04M |
|
$-18.04M |
|
$-19.24M |
|
$-19.72M |
|
52.54M |
|
52.54M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$115.23M |
|
$0.24M |
|
$1.33M |
|
$116.56M |
|
$11.41M |
|
-- |
|
$0.43M |
|
$11.85M |
|
$104.71M |
|
$104.71M |
|
$104.71M |
|
53.33M |
|
| Cash Flow Statement Financials | |
$-73.58M |
|
$70.17M |
|
$0.51M |
|
$40.88M |
|
$37.98M |
|
$-2.89M |
|
|
Stock-Based Compensation |
$5.92M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-73.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.23% |
|
-17.23% |
|
-15.47% |
|
-17.23% |
|
$1.96 |
|
$-1.40 |
|
$-1.40 |
|